Stock listing

NASDAQ:SCLX Scilex Holding Company Stock

Home listing (NASDAQ) of Scilex Holding Company

Follow Scilex Holding Company into a list and get an email when it puts out news.

Share price · NASDAQ:SCLX

$0.566 USD -0.062 (-9.8%)

Close on Nov 20, 2026

Past year -95.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.500 – $0.631 USDNov 20, 2026
Volume
198,279 sharesNov 20, 2026
Market cap
$3.98M USDAt the close on Nov 20, 2026 · price × 7.03M shares outstanding
52-week range
$0.500 – $16.812 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$148,441 USDMedian day 35,200 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Scilex Holding Company logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:SCLX · Home$0.566 USD-0.062 (-9.8%)198,279$0.613$0.631$0.500$0.627Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:SCLX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.566-0.062-9.8%$0.613$0.631$0.500198,279
$0.627-0.015-2.3%$0.642$0.685$0.580188,813
$0.642-0.608-48.6%$1.230$1.230$0.543639,624
$1.250-0.180-12.6%$1.390$1.390$1.24090,573
$1.430-0.130-8.3%$1.550$1.570$1.40258,943
$1.560-0.060-3.7%$1.610$1.658$1.54048,228
$1.620+0.010+0.6%$1.620$1.652$1.61011,800
$1.610-0.130-7.5%$1.740$1.775$1.61030,900
$1.740+0.040+2.4%$1.690$1.770$1.64023,300
$1.7000.0000.0%$1.700$1.780$1.66520,800
$1.700-0.130-7.1%$1.830$1.830$1.61079,900
$1.830-0.020-1.1%$1.950$1.990$1.81032,900
$1.850-0.020-1.1%$1.850$2.000$1.85046,200
$1.870+0.020+1.1%$1.880$2.090$1.85054,900
$1.850-0.210-10.2%$2.050$2.064$1.83049,600
$2.060-0.030-1.4%$2.090$2.170$2.0507,400
$2.090+0.040+2.0%$2.010$2.100$2.01017,000
$2.050-0.280-12.0%$2.320$2.340$2.01099,300
$2.330-0.020-0.9%$2.350$2.400$2.28037,900
$2.350-0.120-4.9%$2.440$2.480$2.27035,200
$2.470-0.090-3.5%$2.560$2.600$2.44933,300
$2.560+0.030+1.2%$2.510$2.620$2.51025,900
$2.530-0.040-1.6%$2.550$2.680$2.52035,700
$2.570-0.260-9.2%$2.810$2.810$2.51852,100
$2.830+0.010+0.4%$2.820$2.890$2.77029,500
$2.820-0.030-1.1%$2.830$2.850$2.77012,500
$2.850-0.030-1.0%$2.880$2.950$2.81026,700
$2.880+0.080+2.9%$2.810$3.225$2.79033,900
$2.800-0.120-4.1%$2.920$2.950$2.80033,800
$2.920-0.040-1.4%$2.960$3.110$2.86049,700
$2.960-0.530-15.2%$3.490$3.592$2.900140,800
$3.490-0.470-11.9%$3.900$3.900$3.44582,100
$3.960+0.140+3.7%$3.870$4.050$3.79057,900
$3.820-0.240-5.9%$4.130$4.490$3.81059,600
$4.060-0.350-7.9%$4.400$4.589$4.000107,800
$4.410-0.040-0.9%$4.490$4.879$4.40016,100
$4.450+0.040+0.9%$4.420$4.690$4.40017,500
$4.410-0.080-1.8%$4.480$4.535$4.35812,000
$4.490-0.400-8.2%$4.890$4.900$4.45073,200
$4.890-0.050-1.0%$5.366$5.366$4.83042,800
$4.940-0.160-3.1%$5.060$5.151$4.92027,300
$5.100-0.250-4.7%$5.350$5.350$5.1008,700
$5.350+0.190+3.7%$5.120$5.420$5.12017,900
$5.160+0.120+2.4%$5.020$5.306$5.00021,500
$5.040-0.330-6.1%$5.360$5.460$5.02027,000
$5.370+0.200+3.9%$5.220$5.600$5.22040,000
$5.170+0.240+4.9%$4.970$5.350$4.97041,200
$4.930-0.170-3.3%$5.100$5.220$4.85042,900
$5.100+0.090+1.8%$4.990$5.200$4.89924,900
$5.010-0.040-0.8%$5.115$5.190$5.00021,600
$5.050-0.150-2.9%$5.190$5.220$5.05020,600
$5.200-0.170-3.2%$5.370$5.425$5.19025,200
$5.370-0.045-0.8%$5.410$5.500$5.30039,000
$5.415+0.135+2.6%$5.410$5.720$5.29040,400
$5.280-0.070-1.3%$5.370$5.450$5.28015,000
$5.350-0.050-0.9%$5.420$5.645$5.27030,500
$5.400-0.095-1.7%$5.510$5.510$5.33041,900
$5.495+0.065+1.2%$5.410$5.530$5.29032,700
$5.430-0.140-2.5%$5.570$5.850$5.40046,700
$5.570-0.040-0.7%$5.650$5.850$5.55762,800
$5.610-0.040-0.7%$5.640$6.200$5.59065,000
$5.650-0.010-0.2%$5.680$5.882$5.56020,939
$5.660-0.070-1.2%$5.790$5.800$5.50058,341
$5.730-0.070-1.2%$5.800$5.910$5.64026,000
$5.800+0.150+2.7%$5.650$5.800$5.46529,700

Splits

2 splits since 2025 · NASDAQ:SCLX · every price before a split is adjusted for it

DayRatioWhat
53-for-33Split
1-for-35Consolidation
Ticker
NASDAQ:SCLX
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Scilex Holding Company news

Scilex Holding Company on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
17 in the last 12 months · 153 in all · newest Jul 7, 2026 · oldest 2021
Decks
21 decks · latest January 2025

Where Scilex Holding Company is listed

ListingExchangeCountryCurrency
NASDAQ:SCLX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:SCLXBOATSUnited StatesUSD
Tradegate:D8B0TradegateGermanyEUR
Frankfurt:D8B0FrankfurtGermanyEUR
Dusseldorf:D8B0DusseldorfGermanyEUR

Valuation

EV/sales 3.1× against a median of 1.3×: 7th lowest of 11 Pharmaceuticals companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$98.96M USD
P/E
Loss
EV/sales
3.1×
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
161.1%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
Negative equity
Beta vs S&P 500
1.46

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Scilex Holding Company · NASDAQ:SCLXUS$3.98MUS$98.96Mn/a3.1×n/an/an/an/a1.46
ChoA Pharmaceutical Co., Ltd. · KRX:034940US$6.59MUS$6.89Mn/a0.1×n/a0.3×−4.6%0.1×n/a
Newbury Pharmaceuticals AB · OMXSTO:NEWBRYUS$5.78MUS$4.87Mn/a1.2×n/a3.0×−53.7%0.0×n/a
Firebrick Pharma Limited · ASX:FREUS$5.51MUS$4.63Mn/a66.0×n/a5.0×n/a0.0×n/a
Universe Pharmaceuticals INC · NASDAQ:UPCUS$5.41M−US$14.09Mn/a0.0×n/a0.1×−20.6%0.2×0.91
Mangalam Drugs & Organics Ltd. · NSE:MANGALAMUS$4.71MUS$4.71Mn/a0.2×n/a0.4×−16.5%0.0×n/a
Vivimed Labs Limited · NSE:VIVIMEDLABUS$4.49MUS$46.53Mn/a6.2×n/an/a−252.1%n/an/a
Acrux Limited · ASX:ACRUS$4.05MUS$4.59Mn/a1.5×n/a4.2×−13.0%1.7×n/a
Scienture Holdings, Inc. · NASDAQ:SCNXUS$3.74MUS$8.36Mn/a5.6×n/a0.1×n/a0.2×1.74
Sanai Health Industry Group Company Limited · HKEX:1889US$2.42M−US$44.61Mn/a−3.5×n/a0.1×−25.7%0.0×n/a
Lasa Supergenerics Ltd. · NSE:LASAUS$2.17MUS$2.17Mn/a3.2×n/a0.4×−260.4%0.0×n/a
Median of the othersUS$4.60MUS$4.67M1.3×0.4×−23.1%0.0×1.33

Forecasts

Analysts' consensus from EODHD, read Nov 15, 2026. Not 6ix's view and not investment advice.

Price target
490.00 USD · Analysts' mean
EPS, year to Dec 2026
-0.89 · 1 analyst

Team and board

Officers

OfficerRole
Henry JiExecutive Chairman, Chief Executive Officer and President

Board

DirectorRole
Henry JiExecutive Chairman, Chief Executive Officer and President
Alexander WuDirector
Dorman Followwill+Director
Jay ChunDirector
Yue Alexander WuDirector

Events

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 20, 2026
Q2 2026Aug 14, 2026−5.0%
Q1 2026Apr 10, 2026 · After close−12.3%
Q4 2025Feb 25, 2026−0.5%
Q3 2025Nov 14, 2025 · After close−12.3%
Q2 2025Aug 13, 2025 · After close−17.3%
Q1 2025May 14, 2025 · After close−7.8%
Q4 2024Mar 31, 2025 · After close−4.4%
Q3 2024Nov 27, 2024+0.6%
Q2 2024Aug 13, 2024 · After close−4.6%
All 20 quarters
QuarterResultsShare move
Q1 2024May 13, 2024 · After close−0.6%
Q4 2023Mar 12, 2024 · Before open−5.7%
Q3 2023Nov 14, 2023 · After close+2.5%
Q2 2023Aug 30, 2023−4.8%
Q1 2023May 12, 2023+24.5%
Q4 2022Mar 7, 2023−12.3%
Q3 2022Nov 4, 2022−12.1%
Q2 2022Aug 12, 20220.0%
Q1 2022May 16, 20220.0%
Q4 2021Feb 24, 20220.0%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (January 2025)Investor deck57 slidesJanuary 2025
Merger or Acquisition (September 2024)Merger or acquisition22 slidesSep 3, 2024
Investor Presentation (September 2024)Investor deck29 slidesSeptember 2024
Investor Presentation (April 2024)Investor deck33 slidesApril 2024
Investor Presentation (January 2024)Investor deck41 slidesJanuary 2024
Investor Presentation (November 2023)Investor deck43 slidesNov 1, 2023
Investor Presentation (October 2023)Investor deck42 slidesOctober 2023
Investor Presentation (October 2023)Investor deck42 slidesOctober 2023
Investor Presentation (October 2023)Investor deck41 slidesOctober 2023
Investor Presentation (July 2023)Investor deck42 slidesJuly 2023
All 21 decks
DeckKindSlidesDate
Investor Presentation (June 2023)Investor deck42 slidesJun 22, 2023
Investor Presentation (May 2023)Investor deck35 slidesMay 2023
Investor Presentation (May 2023)Investor deck39 slidesMay 2023
Investor Presentation (March 2023)Investor deck31 slidesMarch 2023
Investor Presentation (March 2023)Investor deck26 slidesMarch 2023
Investor Presentation (2023)Investor deck56 slides2023
Investor Presentation (December 2022)Investor deck25 slidesDecember 2022
SPAC Merger (March 2022)SPAC merger21 slidesMar 18, 2022
SPAC Merger (February 2022)SPAC merger57 slidesFeb 18, 2022
SPAC Merger (December 2021)SPAC merger57 slidesDecember 2021
Investor Presentation (April 2019)Investor deck27 slidesApril 2019

Open Decks

Financings

RaiseDate
Strategic investment of newly issued shares of common stock
Announced: US$100M · US$10 a share
Buyers: iHolding Group LLP ($100,000,000 of newly issued shares of Semnur common stock)
Use of proceeds: Pipeline advancement incl. Phase 3 SEMDEXA (SP-102), commercialization, acquisitions and partnerships, working capital, IP, general corporate purposes
Jul 7, 2026
Strategic investment of common stock
Announced: US$100M · US$15 a share
Buyers: iHolding Group LLP ($100,000,000 of newly issued shares of common stock at $15.00 per share, approximately 6,666,667 shares)
Use of proceeds: Strategic growth, healthcare and medtech initiatives, product development, acquisitions and partnerships, working capital, IP and general corporate purposes
Jul 6, 2026
Warrant exercise of shares of common stock on exercise of existing warrants
Closed: US$20.3M raised · US$22.51 a share · Warrants at US$29 for 60 months · Rodman & Renshaw LLC +1
Dealers: Rodman & Renshaw LLC (co-lead), StockBlock Securities LLC (co-lead)
Use of proceeds: Working capital and general corporate purposes
Nov 25, 2025
Registered direct offering of common stock, pre-funded warrants and accompanying common warrants
Announced: about US$17M · US$0.59 a share · ½ warrant at US$0.649
Use of proceeds: Working capital and general corporate purposes, including commercialization, R&D, clinical trials, acquisitions and debt repayment
Dec 12, 2024
Warrant exercise of outstanding warrants issued in March 2024
Announced: about US$1M · US$0.59 a share
Dec 12, 2024

Open Financings · Read by 6ix AI from the company's releases

IPO

Went public as Vickers Vantage Corp. I, a blank check company (SPAC). Priced at US$10.00 a unit on Jan 6, 2021.

Price
US$10.00 a unit
Units offered
12,000,000 units
Offering size
US$120 million
Underwriters' option
Up to 1,800,000 more units
Listing
VCKAU on the Nasdaq Capital Market
Underwriter
Maxim Group LLC
Units delivered
On or about Jan 11, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceAug 19, 2020
Filed publiclyDec 15, 2020
Amended onceDec 28, 2020
Shares registered with an exchangeJan 6, 2021
Declared effective by the SECJan 6, 2021
Final prospectus, with the priceJan 8, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Jan 8, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue30.3M56.6M46.7M38.0M31.3M23.6M21.0M
Cost of revenue10.6M16.7M15.7M10.8M3.63M2.15M5.80M
Gross profit125.8M167.4M31.1M27.2M27.7M21.4M15.2M
Research and development20.7M9.64M12.7M9.05M9.20M9.96M85.5M
Selling, general and administrative266.9M119.0M119.6M64.9M50.6M43.0M64.7M
Operating income-346.0M-83.4M-105.4M-50.6M-35.8M-35.3M-138.7M
Depreciation and amortization4.62M4.05M4.15M3.96M3.78M3.78M3.75M
EBITDA-341.4M-79.3M-101.3M-46.7M-32.1M-31.5M-134.9M
Interest expense11.5M1.96M1.07M9.60M11.8M13.1M16.9M
Income before tax-374.0M-72.8M-114.3M-23.4M-88.4M-47.6M-178.6M
Income tax26.0K-1.00K13.0K4.00K5.00K-53.0K2.00K
Net income-374.1M-72.8M-114.3M-23.4M-88.4M-47.5M-178.6M
Earnings per share, basic-36.48-7.24-1.28-0.17-0.67-0.36-44.30
Earnings per share, diluted-36.48-8.05-1.28-0.17-0.67-0.36

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents4.96M3.27M3.92M2.18M4.34M30.5K
Short-term investments6.03M303.8K
Receivables15.2M26.4M34.6M21.2M14.3M13.1M
Inventory4.79M2.44M4.21M1.38M2.56M1.15M
Current assets38.4M41.5M46.8M29.6M23.0M30.5K
Property, plant and equipment13.6M708.0K722.0K772.0K805.0K2.52M
Goodwill13.5M13.5M13.5M13.5M13.5M13.5M
Total assets365.0M93.0M101.3M86.5M77.9M199.5K
Accounts payable86.3M52.6M41.0M8.45M4.28M8.12M
Current liabilities483.7M259.6M250.4M44.8M169.4M180.8K
Long-term debt22.5M845.0K17.0M3.83M107.7M
Total debt132.5M38.0M128.5M0110.0M138.6M
Total liabilities576.7M285.6M274.2M50.3M301.8M180.8K
Shareholders' equity-207.8M-192.6M-172.9M36.2M-223.9M18.7K
Shares outstanding7.03M5.24M100.0M141.3M132.9M3.45M4.03M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations3.82M19.3M-20.7M-21.3M-28.7M-31.5M-60.4M
Capital spending-133.0K0-30.0K-7.00K0-25.0K-584.0K
Free cash flow3.68M19.3M-20.7M-21.3M-28.7M-31.5M-61.0M
Cash from investing4.08M-2.67M-330.0K-2.07M0-25.0K-17.6M
Cash from financing-5.46M-18.1M23.6M21.2M28.2M-19.2M15.8M
Dividends paid-8.65M-8.65M
Share buybacks0-10.0M96.0K140.3M
Change in cash1.68M-1.46M2.54M-2.15M-501.0K-50.7M-62.3M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 20, 2026Current reportSEC
NT 10-Q · Late filing noticeNov 17, 2026Explanation requestSEC
8-K · Current reportNov 17, 2026Current reportSEC
8-K · Current reportSep 29, 2026Material contractSEC
SCHEDULE 13D/A · Big-stake notice, amendedAug 24, 2026Big-stake noticeSEC
4 · Change in ownershipAug 24, 2026Insider tradeSEC
10-Q · Quarterly reportAug 14, 2026Quarterly reportSEC
8-K · Current reportAug 12, 2026Material contractSEC
8-K · Current reportJul 22, 2026Acquisition or disposalSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 7, 2026Big-stake noticeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipJul 7, 2026Insider tradeSEC
8-K · Current reportJul 6, 2026Material contractSEC
S-8 · Registration statement for employee plansJun 29, 2026Offer documentSEC
8-K · Current reportJun 29, 2026Material contractSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 26, 2026Big-stake noticeSEC
4 · Change in ownershipJun 26, 2026Insider tradeSEC
8-K · Current reportJun 24, 2026Meeting outcomeSEC
EFFECT · Notice that a registration is effectiveJun 12, 2026Other filingsSEC
CORRESP · Letter to the SECJun 9, 2026Other filingsSEC
UPLOAD · Letter from the SECJun 9, 2026Other filingsSEC
S-3 · Registration statementJun 2, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveMay 26, 2026Other filingsSEC
10-Q · Quarterly reportMay 20, 2026Quarterly reportSEC
CORRESP · Letter to the SECMay 20, 2026Other filingsSEC
NT 10-Q · Late filing noticeMay 15, 2026Explanation requestSEC
8-K · Current reportMay 11, 2026Current reportSEC
DEFA14A · Additional proxy materialMay 5, 2026Meeting noticeSEC
8-K · Current reportMay 5, 2026Material contractSEC
ARS · Annual report to shareholdersApr 30, 2026Annual reportSEC
DEF 14A · Proxy statementApr 30, 2026Meeting noticeSEC
CORRESP · Letter to the SECApr 30, 2026Other filingsSEC
8-K · Current reportApr 28, 2026Material contractSEC
UPLOAD · Letter from the SECApr 24, 2026Other filingsSEC
4 · Change in ownershipApr 20, 2026Insider tradeSEC
4 · Change in ownershipApr 20, 2026Insider tradeSEC
S-3 · Registration statementApr 16, 2026Offer documentSEC
10-K · Annual reportApr 10, 2026Annual reportSEC
NT 10-K · Late filing noticeApr 1, 2026Explanation requestSEC
8-K · Current reportMar 13, 2026Current reportSEC
8-K · Current reportMar 13, 2026Current reportSEC
424B3 · ProspectusFeb 20, 2026Offer documentSEC
424B3 · ProspectusFeb 20, 2026Offer documentSEC
424B3 · ProspectusFeb 20, 2026Offer documentSEC
8-K · Current reportFeb 20, 2026Material contractSEC
UPLOAD · Letter from the SECFeb 20, 2026Other filingsSEC
DRS · Draft registration statementFeb 13, 2026Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
S-8 · Registration statement for employee plansFeb 6, 2026Offer documentSEC
8-K · Current reportFeb 3, 2026Current reportSEC
8-K · Current reportFeb 2, 2026Material contractSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 14, 2026Big-stake noticeSEC
4 · Change in ownershipJan 14, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 8, 2026Big-stake noticeSEC
4 · Change in ownershipJan 8, 2026Insider tradeSEC
RW · Request to withdraw a registrationJan 6, 2026Other filingsSEC
SCHEDULE 13D/A · Big-stake notice, amendedDec 31, 2025Big-stake noticeSEC
4/A · Change in ownership, amendedDec 31, 2025Insider tradeSEC
4 · Change in ownershipDec 30, 2025Insider tradeSEC
8-K · Current reportDec 30, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveDec 30, 2025Other filingsSEC
424B3 · ProspectusDec 29, 2025Offer documentSEC
CORRESP · Letter to the SECDec 23, 2025Other filingsSEC
8-K · Current reportDec 22, 2025Current reportSEC
424B3 · ProspectusDec 17, 2025Offer documentSEC
424B3 · ProspectusDec 17, 2025Offer documentSEC
424B3 · ProspectusDec 17, 2025Offer documentSEC
8-K · Current reportDec 17, 2025Material contractSEC
S-1 · Registration statementDec 15, 2025Offer documentSEC
424B3 · ProspectusDec 12, 2025Offer documentSEC
424B3 · ProspectusDec 12, 2025Offer documentSEC
424B3 · ProspectusDec 12, 2025Offer documentSEC
8-K · Current reportDec 12, 2025Material contractSEC
424B3 · ProspectusDec 11, 2025Offer documentSEC
424B3 · ProspectusDec 11, 2025Offer documentSEC
424B3 · ProspectusDec 11, 2025Offer documentSEC
8-K · Current reportDec 11, 2025Management or board changeSEC
424B3 · ProspectusDec 5, 2025Offer documentSEC
424B3 · ProspectusDec 5, 2025Offer documentSEC
424B3 · ProspectusDec 5, 2025Offer documentSEC
8-K · Current reportDec 5, 2025Material contractSEC
UPLOAD · Letter from the SECDec 4, 2025Other filingsSEC
SCHEDULE 13D · Big-stake noticeDec 1, 2025Big-stake noticeSEC
424B3 · ProspectusDec 1, 2025Offer documentSEC
424B3 · ProspectusDec 1, 2025Offer documentSEC
424B3 · ProspectusDec 1, 2025Offer documentSEC
8-K · Current reportDec 1, 2025Acquisition or disposalSEC
4 · Change in ownershipNov 28, 2025Insider tradeSEC
3 · Initial statement of ownershipNov 28, 2025Insider tradeSEC
424B3 · ProspectusNov 24, 2025Offer documentSEC
424B3 · ProspectusNov 24, 2025Offer documentSEC
424B3 · ProspectusNov 24, 2025Offer documentSEC
8-K · Current reportNov 24, 2025Material contractSEC
424B3 · ProspectusNov 14, 2025Offer documentSEC
424B3 · ProspectusNov 14, 2025Offer documentSEC
424B3 · ProspectusNov 14, 2025Offer documentSEC
10-Q · Quarterly reportNov 14, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
DEF 14A · Proxy statementNov 7, 2025Meeting noticeSEC
424B3 · ProspectusNov 4, 2025Offer documentSEC
424B3 · ProspectusNov 4, 2025Offer documentSEC
424B3 · ProspectusNov 4, 2025Offer documentSEC
8-K · Current reportNov 4, 2025Material contractSEC
424B3 · ProspectusOct 31, 2025Offer documentSEC
424B3 · ProspectusOct 31, 2025Offer documentSEC
424B3 · ProspectusOct 31, 2025Offer documentSEC
8-K · Current reportOct 31, 2025Current reportSEC
PRE 14A · Preliminary proxy statementOct 28, 2025Meeting noticeSEC
DOct 14, 2025Other filingsSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 14, 2025Big-stake noticeSEC
4 · Change in ownershipOct 9, 2025Insider tradeSEC
4 · Change in ownershipOct 9, 2025Insider tradeSEC
4 · Change in ownershipOct 9, 2025Insider tradeSEC
4 · Change in ownershipOct 9, 2025Insider tradeSEC
4 · Change in ownershipOct 9, 2025Insider tradeSEC
424B3 · ProspectusOct 7, 2025Offer documentSEC
424B3 · ProspectusOct 7, 2025Offer documentSEC
424B3 · ProspectusOct 7, 2025Offer documentSEC
8-K · Current reportOct 7, 2025Management or board changeSEC
SCHEDULE 13D · Big-stake noticeOct 2, 2025Big-stake noticeSEC
424B3 · ProspectusOct 1, 2025Offer documentSEC
424B3 · ProspectusOct 1, 2025Offer documentSEC
424B3 · ProspectusOct 1, 2025Offer documentSEC
8-K · Current reportOct 1, 2025Material contractSEC
424B3 · ProspectusSep 26, 2025Offer documentSEC
424B3 · ProspectusSep 26, 2025Offer documentSEC
424B3 · ProspectusSep 26, 2025Offer documentSEC
8-K · Current reportSep 26, 2025Acquisition or disposalSEC
SCHEDULE 13D · Big-stake noticeSep 26, 2025Big-stake noticeSEC
8-K · Current reportSep 26, 2025Acquisition or disposalSEC
8-K · Current reportSep 26, 2025Management or board changeSEC
4 · Change in ownershipSep 25, 2025Insider tradeSEC
3 · Initial statement of ownershipSep 23, 2025Insider tradeSEC
CORRESP · Letter to the SECAug 29, 2025Other filingsSEC
424B3 · ProspectusAug 21, 2025Offer documentSEC
424B3 · ProspectusAug 21, 2025Offer documentSEC
424B3 · ProspectusAug 21, 2025Offer documentSEC
8-K · Current reportAug 21, 2025Management or board changeSEC
UPLOAD · Letter from the SECAug 20, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
424B3 · ProspectusAug 13, 2025Offer documentSEC
424B3 · ProspectusAug 13, 2025Offer documentSEC
424B3 · ProspectusAug 13, 2025Offer documentSEC
10-Q · Quarterly reportAug 13, 2025Quarterly reportSEC
S-1 · Registration statementAug 4, 2025Offer documentSEC
424B3 · ProspectusJul 23, 2025Offer documentSEC
424B3 · ProspectusJul 23, 2025Offer documentSEC
424B3 · ProspectusJul 23, 2025Offer documentSEC
8-K · Current reportJul 23, 2025Material contractSEC
8-K · Current reportJul 23, 2025Material contractSEC
424B3 · ProspectusJun 24, 2025Offer documentSEC
424B3 · ProspectusJun 24, 2025Offer documentSEC
424B3 · ProspectusJun 24, 2025Offer documentSEC
8-K · Current reportJun 23, 2025Current reportSEC
8-K · Current reportJun 23, 2025Meeting outcomeSEC
8-K · Current reportJun 4, 2025Current reportSEC
ARS · Annual report to shareholdersMay 16, 2025Annual reportSEC
DEF 14A · Proxy statementMay 16, 2025Meeting noticeSEC
424B3 · ProspectusMay 15, 2025Offer documentSEC
424B3 · ProspectusMay 15, 2025Offer documentSEC
424B3 · ProspectusMay 15, 2025Offer documentSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
424B3 · ProspectusMay 14, 2025Offer documentSEC
424B3 · ProspectusMay 14, 2025Offer documentSEC
424B3 · ProspectusMay 14, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveMay 14, 2025Other filingsSEC
EFFECT · Notice that a registration is effectiveMay 14, 2025Other filingsSEC
EFFECT · Notice that a registration is effectiveMay 14, 2025Other filingsSEC
8-K · Current reportMay 12, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 8, 2025Big-stake noticeSEC
POS AM · Amendment to an effective registrationMay 7, 2025Offer documentSEC
POS AM · Amendment to an effective registrationMay 7, 2025Offer documentSEC
POS AM · Amendment to an effective registrationMay 7, 2025Offer documentSEC
8-K · Current reportApr 30, 2025Current reportSEC
10-K/A · Annual report, amendedApr 29, 2025Annual reportSEC
8-K · Current reportApr 22, 2025Current reportSEC
8-K · Current reportApr 21, 2025Material contractSEC
8-K · Current reportApr 15, 2025Current reportSEC
8-K · Current reportApr 11, 2025Current reportSEC
S-8 · Registration statement for employee plansApr 1, 2025Offer documentSEC
10-K · Annual reportMar 31, 2025Annual reportSEC
424B3 · ProspectusMar 20, 2025Offer documentSEC
424B3 · ProspectusMar 20, 2025Offer documentSEC
8-K · Current reportMar 20, 2025Meeting outcomeSEC
8-K · Current reportMar 10, 2025Current reportSEC
424B3 · ProspectusMar 5, 2025Offer documentSEC
424B3 · ProspectusMar 3, 2025Offer documentSEC
424B3 · ProspectusMar 3, 2025Offer documentSEC
8-K · Current reportMar 3, 2025Current reportSEC
8-K · Current reportMar 3, 2025Material contractSEC
424B3 · ProspectusFeb 27, 2025Offer documentSEC
424B3 · ProspectusFeb 27, 2025Offer documentSEC
DEF 14A · Proxy statementFeb 27, 2025Meeting noticeSEC
8-K · Current reportFeb 27, 2025Material contractSEC
PRER14AFeb 26, 2025Other filingsSEC
PRE 14A · Preliminary proxy statementFeb 14, 2025Meeting noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 23, 2025Big-stake noticeSEC
4 · Change in ownershipJan 23, 2025Insider tradeSEC
424B3 · ProspectusJan 22, 2025Offer documentSEC
424B3 · ProspectusJan 22, 2025Offer documentSEC
8-K · Current reportJan 22, 2025Material contractSEC

This page holds 200 of 745 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Scilex Holding Company’s releases · as of Jul 7, 2026

Common shares
7,034,737
Fully diluted
7,034,737

Fully diluted

LineShares
Common shares7,034,737

Warrants and options

Lot
Warrants · US$29.00 · expire about Nov 2030

Share count over time

CountShares
Nov 22, 20267,034,737

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard350K4.1%US$1.56MSep 30, 2026
Jacobs Levy Equity Management, Inc113K1.3%US$504KSep 30, 2026
BlackRock94,6741.1%US$421KSep 30, 2026
State Street35,0320.41%US$156KSep 30, 2026
Marshall Wace, LLP33,8000.40%US$150KSep 30, 2026
UBS31,4110.37%US$140KSep 30, 2026
Renaissance Technologies31,3640.37%US$140KSep 30, 2026
Ashton Thomas Private Wealth, LLC23,8320.28%US$106KSep 30, 2026
Hrt Financial LP22,4740.26%US$100KSep 30, 2026
T. Rowe Price20,9200.25%US$94,000Sep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Citadel19,3710.23%US$86,201Sep 30, 2026
Northern Trust15,0420.18%US$66,937Sep 30, 2026
Rockefeller Capital Management L.P.2,8200.03%US$12,549Sep 30, 2026
Morgan Stanley2,7440.03%US$12,214Sep 30, 2026
US Bancorp \de\2,0040.02%US$8,918Sep 30, 2026
Creative Financial Designs Inc1,8530.02%US$8,246Sep 30, 2026
Jones Financial Companies Lllp1,7180.02%US$8,401Sep 30, 2026
RBC1,5610.02%US$7,000Sep 30, 2026
Larson Financial Group LLC1,4190.02%US$6,315Sep 30, 2026
Migdal Insurance & Financial Holdings Ltd.1,3780.02%US$6,132Sep 30, 2026
Osaic Holdings, Inc.1,0360.01%US$4,567Sep 30, 2026
DWS800<0.01%US$3,560Sep 30, 2026
Barclays616<0.01%US$2,741Sep 30, 2026
IFP Advisors, Inc576<0.01%US$2,563Sep 30, 2026
Transce3nd, LLC500<0.01%US$1,280Sep 30, 2026
Activest Wealth Management302<0.01%US$1,344Sep 30, 2026
Klp Kapitalforvaltning As290<0.01%US$1,291Sep 30, 2026
BROOKFIELD Corp265<0.01%US$1,179Sep 30, 2026
S&T Bank78<0.01%US$347Sep 30, 2026
Wells Fargo57<0.01%US$254Sep 30, 2026
Zurcher Kantonalbank (Zurich Cantonalbank)44<0.01%US$196Sep 30, 2026
Tower Research Capital LLC (TRC)35<0.01%US$156Sep 30, 2026
Rhumbline Advisers35<0.01%US$155Sep 30, 2026
Northwestern Mutual Wealth Management Co33<0.01%US$146Sep 30, 2026
TD28<0.01%US$123Sep 30, 2026
Global Retirement Partners, LLC27<0.01%US$120Sep 30, 2026
New England Capital Financial Advisors LLC23<0.01%US$103Sep 30, 2026
NFSG Corp22<0.01%US$98Sep 30, 2026
Allworth Financial LP18<0.01%US$81Sep 30, 2026
BNP Paribas18<0.01%US$80Sep 30, 2026
BFC Planning, Inc.17<0.01%US$76Sep 30, 2026
Root Financial Partners, LLC17<0.01%US$76Sep 30, 2026
National Bank Of Canada15<0.01%US$67Sep 30, 2026
Pacifica Partners Inc.14<0.01%US$62Sep 30, 2026
NewEdge Advisors, LLC14<0.01%US$62Sep 30, 2026
CoreCap Advisors, LLC12<0.01%US$53Sep 30, 2026
Valley National Advisers Inc12<0.01%US$54Sep 30, 2026
Harbour Investments, Inc.10<0.01%US$45Sep 30, 2026
SOA Wealth Advisors, LLC.8<0.01%US$36Sep 30, 2026
Steward Partners Investment Advisory, LLC8<0.01%US$36Sep 30, 2026

This page holds 50 of 70 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund218K2.6%US$1.7MJun 30, 2026
Vanguard Extended Market Index Fund76,2300.90%US$595KJun 30, 2026
iShares Micro-Cap ETF23,9350.28%US$187KJun 30, 2026
iShares Core S&P Total U.S. Stock Market ETF14,7420.17%US$115KJun 30, 2026
T. Rowe Price Extended Equity Market Index Fund6,9000.08%US$53,820Jun 30, 2026
Vanguard Institutional Total Stock Market Index Fund3,8050.04%US$29,679Jun 30, 2026
Vanguard Balanced Index Fund3,7470.04%US$29,227Jun 30, 2026
1290 VT Micro Cap Portfolio1,6830.02%US$13,127Jun 30, 2026
MetLife Russell 2000 Index Portfolio627<0.01%US$4,891Jun 30, 2026
Siit Extended Market Index Fund344<0.01%US$3,062May 31, 2026
All 14 holders
HolderSharesOf the companyValueAs of
State Street Balanced Index Fund120<0.01%US$936Jun 30, 2026
Avantis Total Equity Markets ETF80<0.01%US$712May 31, 2026
Dimensional US Core Equity Market ETF66<0.01%US$440Jul 31, 2026
LVIP Dimensional U.S. Core Equity 2 Fund39<0.01%US$304Jun 30, 2026

Big stakes

StakeStakeSharesDateFiling
SCLX Stock Acquisition JV LLC11.40%30MJul 3, 2026Schedule 13D
Armistice Capital, LLC8.65%4.8MJun 30, 2025Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Tommy G Thompson
Other companies: Healthpeak Properties, Inc. (Director · Since at least Mar 1, 2024); TherapeuticsMD, Inc. (Director · Since at least Aug 20, 2015); United Therapeutics Corporation (Director · Since at least Jun 26, 2015); Tyme Technologies Inc (Director · Feb 6, 2018 – Aug 22, 2019 · Past); Physicians Realty Trust (Director · Aug 31, 2015 – Mar 1, 2024 · Past); Centene Corporation (Director · Jun 30, 2015 – Dec 31, 2021 · Past)
Director · Nov 10, 2022 – Jan 17, 2023 · Past
Elizabeth Czerepak
Other companies: TransCode Therapeutics, Inc. (CFO, Director · Since at least Oct 6, 2025); Delcath Systems, Inc. (DIRECTOR · Since at least Feb 14, 2020); Sorrento Therapeutics, Inc. (EVP & Chief Financial Officer · Nov 15, 2021 – May 18, 2022 · Past); Spectrum Pharmaceuticals Inc (Director · Jun 19, 2019 – Jun 18, 2020 · Past)
See Remarks · Nov 10, 2022 – Jan 17, 2023 · Past
Henry Ji
Other companies: Semnur Pharmaceuticals, Inc. (Executive Chairman, Chief Executive Officer and President · Since at least Nov 5, 2026); Sorrento Therapeutics, Inc. (Chairman, President and CEO · Since at least Nov 5, 2026)
Executive Chairman, Chief Executive Officer and President · Since at least Jan 30, 2026
Yue Alexander Wu
Other companies: Semnur Pharmaceuticals, Inc. (Director · Since at least Sep 22, 2025); Sorrento Therapeutics, Inc. (Director · Aug 1, 2016 – Aug 30, 2021 · Past)
Director · Since at least Sep 22, 2023
Alexander Wu
Other companies: Semnur Pharmaceuticals, Inc. (Director · Since at least Nov 5, 2026)
Director · Since at least Nov 5, 2026
Dorman Followwill
Other companies: Semnur Pharmaceuticals, Inc. (Director · Since at least Sep 22, 2025)
Director · Since at least Nov 10, 2022
Jay Chun
Other companies: Semnur Pharmaceuticals, Inc. (Director · Since at least Nov 5, 2026)
Director · Since at least Dec 10, 2024
Jeffrey Chi
Other companies: Aardvark Therapeutics, Inc. (Vice Chairman · Since at least Feb 12, 2025)
Director · Jan 6, 2021 – Jan 6, 2021 · Past
Suneel G KajiDirector · Jan 6, 2021 – Jan 6, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about Scilex Holding Company.